Showing results (181-190 of 463) with videos related to

Sort By:
Pageof 47
European Journal of Neurology|September 18, 2008
EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseasesI Elovaara, S Apostolski, P van Doorn, et al.
Clinical Pharmacokinetics|May 4, 2016
The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant RecipientsAgnieszka A Prytuła, Karlien Cransberg, Antonia H M Bouts, et al.
Cancer Treatment Reviews|December 3, 2023
Review - The impact of pharmacogenetics on the outcome of immune checkpoint inhibitorsKarlijn de Joode, Niels Heersche, Edwin A Basak, et al.
Therapeutic Drug Monitoring|June 30, 2018
Liquid Biopsies to Monitor Solid Organ Transplant Function: A Review of New BiomarkersJeroen G H P Verhoeven, Karin Boer, Ron H N Van Schaik, et al.
Frontiers in Psychiatry|August 23, 2018
No Effect of Dose Adjustment to the CYP2D6 Genotype in Patients With Severe Mental IllnessAnne B Koopmans, David J Vinkers, Igmar T Poulina, et al.
Renal Failure|February 4, 2015
Association of CYP3A variants with kidney transplant outcomesCarol Traynor, Peter Conlon, Paul J Phelan, et al.
Pharmacogenomics|January 19, 2013
CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycinLaure Elens, Annemieke Nieuweboer, Stephen J Clarke, et al.
Pharmacy World & Science : PWS|December 1, 2009
CYP2D6*4, CYP3A5*3 and ABCB1 3435T polymorphisms and drug-related falls in elderly peopleMaren I Blonk, Nathalie van der Velde, Patricia M L A van den Bemt, et al.
Neurocritical Care|November 19, 2014
Feasibility and diagnostic accuracy of early electrophysiological recordings for ICU-acquired weakness: an observational cohort studyLuuk Wieske, Camiel Verhamme, Esther Witteveen, et al.
Cancer Chemotherapy and Pharmacology|March 13, 2015
Pharmacokinetically based dosing of weekly paclitaxel to reduce drug-related neurotoxicity based on a single sample strategyStefanie Kraff, Annemieke J M Nieuweboer, Ron H J Mathijssen, et al.
Pageof 47